Full-Time

Director of Digital Brand Marketing

Posted on 11/30/2025

Edwards Lifesciences

Edwards Lifesciences

10,001+ employees

Develops transcatheter heart valves and devices

Compensation Overview

$156k - $221k/yr

+ Performance-based Incentives

Naperville, IL, USA

In Person

Category
Growth & Marketing (1)
Required Skills
Hubspot
Hootsuite
SEO
Salesforce
Google Analytics
Requirements
  • Bachelor’s degree with experience in related field and related experience in marketing or equivalent experience based on Edwards' criteria
  • Minimum 12 years of work experience in brand and digital marketing in healthcare, health-tech and/or MedTech industry.
  • Proven track record of building and scaling brands and digital strategies.
  • Strong analytical skills and experience with marketing analytics tools (e.g., Google Analytics, HubSpot, etc.).
  • Experience with marketing automation platforms and tools required (e.g., , web CMS, CRM, ABM platforms); Other platforms preferred (e.g., Marketo, Salesforce.com, Hootsuite)
  • Excellent communication, leadership, and project management skills.
  • Experience in technology and consumer marketing is a plus.
Responsibilities
  • Develop and articulate a compelling brand vision that aligns with the company’s mission, values, and long-term strategic goals.
  • Lead brand architecture and positioning efforts to ensure clarity and differentiation in the market.
  • Oversee the creation and evolution of brand guidelines, ensuring consistency across all internal and external communications.
  • Conduct regular brand health assessments using customer insights, market trends, and competitive analysis to inform strategic decisions.
  • Create marketing and brand plans, tools and collateral for multiple products or portfolio. Identify new target segments and deliver positioning options with implications globally. Partner with existing agencies to create plans and implement innovative marketing approaches/tools and may identify new vendors based on needs of the business. Coach marketing team members on agency vendor management.
  • Design and execute comprehensive digital marketing strategies that drive awareness, engagement, and conversion across all digital platforms.
  • Manage and optimize performance marketing campaigns (PPC, display, retargeting, affiliate) to maximize ROI and customer acquisition.
  • Oversee content strategy and development for web, social media, email, and other digital channels, ensuring alignment with brand voice and audience needs.
  • Lead SEO/SEM initiatives to improve organic visibility and search rankings.
  • Implement and manage marketing automation tools and CRM systems to streamline campaign execution and lead nurturing.
  • Define a primary set of digital key performance indicators (KPIs); develop and manage a dashboard reflecting progress toward each KPI.
  • Monitor KPIs across all digital channels, using analytics tools to track performance and identify opportunities for improvement. Educate and inform cross-functional teams on program performance.
  • Translate data insights into actionable strategies that enhance customer experience and drive business growth.
  • Develop dashboards and reporting frameworks for executive leadership to assess marketing impact and ROI.
  • Build, lead, and mentor a multidisciplinary marketing team, fostering a culture of creativity, accountability, and continuous learning.
  • Collaborate closely with Sales, Product, and Customer Experience teams to ensure alignment on go-to-market strategies and customer journey optimization.
  • Manage relationships with creative agencies, media partners, and technology vendors to ensure high-quality execution and innovation.
  • Identify, vet, and educate the organization on new technologies, infrastructure and solutions that improve and optimize initiatives within the business.
  • Stay ahead of emerging digital trends, technologies, and consumer behaviors to keep the brand relevant and competitive.
  • Pilot new marketing channels and tools, evaluating their potential to scale and contribute to business objectives.
  • Champion a test-and-learn approach to campaign development, encouraging experimentation and agility.
  • Partner closely with key thought leaders to anticipate the future market environment, changes in economic climate, the onset of new competitors including substitutes and adjacent players and to predict/drive future needs for current and future customers
  • Collect and interpret voice of customer (VOC) in order to define market requirements and independently design market research and intelligence strategies for a group of complex products within a portfolio
  • Develop and plan larger and more complex marketing programs and activities with accountability for successful completion of all project deliverables
  • Create, communicate and execute global market strategies and actionable market plans to advance the business and generate value within a portfolio across a group of multiple complex products
  • Identify and evaluate more complex marketing process improvements and/or course correction/alignment opportunities
  • Provide direction and guidance to project teams to execute larger marketing projects, initiatives and/or programs
Desired Qualifications
  • 8+ years of experience in brand and digital marketing leadership role.
  • Demonstrated brand and digital marketing skills.
  • Proficient in Microsoft Office Suite and related tools and systems
  • Excellent problem-solving, organizational, analytical and critical thinking skills including high discretion/judgment in decision making
  • Excellent written and verbal communication skills and interpersonal relationship skills including negotiating and relationship management skills with ability to drive achievement of objectives
  • Expert understanding of digital marketing procedures while identifying applications of functional knowledge and existing methodologies to complex problems
  • Expert understanding related aspects of digital marketing processes and/or systems
  • Expert knowledge of financial mechanism that relates to digital marketing
  • Demonstrated ability to direct teams and provide coaching and feedback, including responsibility for all employee actions including hire/fire authority and partnering with HR on all aspects of employee relations
  • Ability to develop and integrate metrics into the projects and operations that clearly demonstrate the value of digital to the business
  • Ability to frequently interact with internal and external management and senior-level stakeholders concerning projects, operational decisions, scheduling requirements, and/or contractual clarifications
  • Ability to provide leadership and direction to cross-functional teams to successfully implement global enterprise systems and related solutions
  • Ability to work and excel within a fast paced, dynamic, and constantly changing work environment
  • Proven successful project management skills
  • Proven experience in articulating digital initiatives and educate other members of the organization by contributing to the development of new concepts, techniques, and standards
  • Experience working with complex B2B sales processes or Technology/Medical Devices/Pharma industry
  • Excellent documentation and communication skills and interpersonal relationship skills including negotiating and relationship management skills with ability to drive achievement of objectives
  • Ability to interact professionally with all organizational levels and proactively escalate issues to appropriate levels of management in the organization
  • Recognized as an expert in own area with specialized depth within the organization
  • Expert knowledge and understanding of brand strategy
  • Expert knowledge and understanding of digital campaigns, tools, and landscape
  • Expert understanding of related aspects of applying marketing concepts and principles to digital channels
  • Strict attention to detail
  • Ability to interact professionally with all organizational levels and proactively escalate issues to appropriate levels of management in the organization
  • Ability to manage competing priorities in a fast paced environment
  • Adhere to all company rules and requirements (e.g., pandemic protocols, Environmental Health & Safety rules) and take adequate control measures in preventing injuries to themselves and others as well as to the protection of environment and prevention of pollution under their span of influence/control

Edwards Lifesciences focuses on cardiovascular medical technologies, especially transcatheter heart valves. Its products enable repairing or replacing diseased heart valves through minimally invasive procedures rather than open-heart surgery. The company builds on a long history that began with the Starr-Edwards valve and now centers on valve therapies and related diagnostics to treat heart disease. It differentiates itself by specializing in valve technologies and transcatheter approaches, backed by a track record of clinical leadership and global reach. The goal is to improve patient outcomes by providing safer, less invasive valve treatment options for people around the world.

Company Size

10,001+

Company Stage

IPO

Headquarters

Irvine, California

Founded

1958

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 sales hit $1.65B, up 12.7% constant currency, raising 2026 guidance to 9-11% growth.
  • Transcatheter Mitral and Tricuspid Therapies grew over 50% YoY to $173M in Q1 2026.
  • Philips EchoNavigator R5.0 FDA clearance on March 27, 2026, enhances Pascal Ace procedures.

What critics are saying

  • Abbott MitraClip erodes Pascal Ace share with 60-80% dominance in 12-24 months.
  • Medtronic Evolut FX captures 10-15% Sapien TAVR revenue in 6-12 months.
  • New CFO Mistras disrupts strategy, causing investor sell-off in 3-6 months.

What makes Edwards Lifesciences unique

  • Pioneered Starr-Edwards mitral valve in 1960, first commercially available artificial heart valve.
  • Global leader in transcatheter aortic valve replacement with Sapien franchise generating $1.2B Q1 2026.
  • Shifted to pure-play structural heart focus post-$4.2B Critical Care sale to BD.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Company News

Informa Markets Engineering
Apr 5th, 2026
Vdyne granted IDE to address 'forgotten' valve.

Vdyne granted IDE to address 'forgotten' valve. Vdyne secures IDE approval to launch a pivotal trial for its TTVR system, positioning itself as a key competitor to Edwards Lifesciences in the growing tricuspid valve replacement market. Omar Ford, Editor-in-Chief, MD+DI, Informa Markets - Engineering April 5, 2026 At a glance. * The tricuspid valve market sees growing competition among top players. * The TTVR system targets patients with severe tricuspid regurgitation. * Edwards' Evoque shows strong data at ACC 75th Annual Expo. Vdyne has been granted an IDE to begin a pivotal trial of its transcatheter tricuspid valve replacement system (TTVR). The device will treat patients suffering from severe tricuspid regurgitation. There is a significant market opportunity for the tricuspid valve, often dubbed the "forgotten valve". "This is a defining milestone for Vdyne and an important step toward bringing a much-needed therapy to patients with severe tricuspid regurgitation," said Mike Buck, Chief Executive Officer. "Our focus now is on disciplined clinical execution and partnering with leading investigators to generate high-quality data that advances the field and improves patient care." Vdyne's TTVR system is designed as a patient-tailored, minimally invasive solution to address the complexities of tricuspid valve anatomy and disease. Since its first-in-human use in November 2023, Vdyne said its TTVR system has been used through clinical studies and compassionate use, providing important insights into procedural performance and clinical outcomes. Vdyne's leading competitors in the TTVR market. Vdyne's IDE comes hot on the heels of Edwards Lifesciences presenting strong data at the American College of Cardiology 75th Annual Scientific Session & Expo. During a late-breaking research session, the Irvine, CA-based company revealed two-year data that show its Evoque TTVR system demonstrated significant and sustained patient benefits. Edwards is first to the market with a TTVR system and secured CE mark for Evoque in October of 2023. It won FDA approval for the device in February of 2024. Edwards, which is on the Top 100 Medical Device Companies list, inherited Envoque when it acquired CardiAQ in 2015 for $400 million. There are other companies that are developing TTVR systems. Medtronic, another firm on the Top 100 Medical Device Companies list, scored a breakthrough designation for the Intrepid TTVR system. Medtronic gained access to Intrepid when it acquired Twelve Inc. for about $458 million in 2015. Editor-in-Chief, MD+DI, Informa Markets - Engineering Omar Ford is a seasoned journalist specializing in medical technology, healthcare innovation, and the medical device and diagnostics industry. As the editor-in-chief of Medical Device + Diagnostics Industry (MD+DI), he has earned a reputation as a leading authority in the field, offering in-depth insights into the latest trends, regulatory changes, and technological advancements shaping the future of healthcare. Omar has been a featured speaker at MD&M and MEDevice events. Omar has written for several publications prior to MD+DI. He is a former contributor at Bioworld Medtech, an online publication owned by Clarivate. He was a general assignment reporter for the Beaufort Gazette and an education and county reporter for the Griffin Daily News. He is the 2001 winner of the Judson Chapman Award from the South Carolina Press Association and the 2003 McClatchy President's Award recipient. Omar has a bachelor's degree in print journalism from the University of South Carolina. Throughout his tenure at MD+DI, Omar has covered a wide array of topics, including medical technology innovations, regulatory affairs, market dynamics, and the growing impact of artificial intelligence in healthcare. Omar is the host of the Let's Talk Medtech podcast.

EMERGENCY USA
Apr 2nd, 2026
Every Heartbeat Matters | EMERGENCY USA attends Partner Summit.

Every Heartbeat Matters | EMERGENCY USA attends Partner Summit. * April 2, 2026 * Events Last week, an EMERGENCY delegation had the opportunity to attend the Every Heartbeat Matters Partner Summit - hosted by Edwards Lifesciences and the Edwards Lifesciences Foundation - alongside other global partners, clinicians, and advocates who share its belief that access to high-quality cardiac care should never depend on where a person is born. Throughout the Summit, likeminded organizations working across surgery, advocacy, training, and systems strengthening reflected on the incredible strides taken so far, shared current progress and challenges, and highlighted the urgent work ahead. The EMERGENCY team also had the opportunity to take part in a Pro Bono Workshop, collaborating directly with Edwards' employees to identify challenges and build roadmaps for solution implementation. Between 2020 and 2025, partners of Edwards' Every Heartbeat Matters initiative impacted over 3.5 million patients who would otherwise have faced barriers to care. Their 2030 vision aims to reach two million more - and EMERGENCY USA is eager to help achieve that goal. Thank you to Edwards Lifesciences for demonstrating leadership and a strong commitment to equitable cardiac care worldwide. Together, Emergency USA is advancing a world where every heartbeat is valued, and every patient has the right to access quality care, free of charge.

Yahoo Finance
Mar 27th, 2026
Philips wins FDA clearance for AI-powered heart imaging device developed with Edwards

Philips has received FDA 510(k) clearance for EchoNavigator R5.0 with DeviceGuide, a heart procedure visualisation tool developed with Edwards Lifesciences. The system uses artificial intelligence to track and visualise mitral valve repair devices during minimally invasive procedures. The software combines X-ray fluoroscopy and 3D transesophageal echocardiography outputs to continuously show device location, addressing the challenge of interpreting separate images during transcatheter edge-to-edge repair procedures. The system is designed for use with Edwards' Pascal Ace mitral valve repair system. A recent study of 51 patients found over two-thirds of users rated the software helpful or very helpful, with teams reporting improved discussions about optimal device trajectory in 85% of cases. The clearance updates a product originally launched in 2012.

MedTech Dive
Mar 27th, 2026
Philips wins FDA clearance for imaging device developed with Edwards.

Philips wins FDA clearance for imaging device developed with Edwards. The system uses AI to optimize the placement of Edwards' mitral valve repair device. Published March 27, 2026 Dive brief: * Philips said Thursday it has received 510(k) clearance for a heart procedure visualization tool it developed with Edwards Lifesciences. * The system, called EchoNavigator R5.0 with DeviceGuide, uses artificial intelligence to enable surgeons to track and visualize mitral valve repair devices during minimally invasive heart procedures. * Philips said the system is intended for use with Edwards' Pascal Ace mitral valve repair system, which competes with Abbott's MitraClip for the transcatheter edge-to-edge repair market. Dive insight: Physicians use X-ray fluoroscopy and 3D transesophageal echocardiography to visualize the heart and device during TEER procedures. However, the technologies create two separate images. The surgical team must interpret where the device is in the body based on the two images, potentially leading to miscommunication and suboptimal device placement. Philips designed its software to combine the outputs of the two imaging modalities to continuously show the location of the device in the body. By visualizing the device in the ultrasound image, the companies aim to enable surgeons to more consistently place the repair system in the optimal location. A paper published this month reported the experiences of physicians who used the system to treat 51 patients. More than two-thirds of users said the software was helpful or very helpful. The 4% of users who said the system was not helpful mainly had device recognition issues in patients with multiple heart implants. Teams said the software improved discussions about optimal trajectory in 85% of cases. The Food and Drug Administration clearance, which updates a product that originally launched in 2012, comes four months after Philips said it was working with Edwards. Philips had already filed for 510(k) clearance when it disclosed the alliance. The collaboration combined Philips' imaging and AI capabilities with Edwards' valvular heart therapy expertise. Bert van Meurs, chief business leader of image-guided therapy at Philips, said at the company's capital markets day last month that DeviceGuide is "a concrete example of how we make emerging complex therapies easier to adopt and scale." Developing such products is only possible by partnering with leading companies in the field, such as Edwards, van Meurs said.

Yahoo Finance
Mar 21st, 2026
Edwards Lifesciences sells critical care unit for $4.2B, shifts focus to high-growth heart therapies

Edwards Lifesciences Corporation has completed its transition into a pure-play structural heart disease company following the divestiture of its Critical Care business to Becton, Dickinson and Company for $4.2 billion in cash. The loss of roughly 20% of its 2023 EBITDA has been offset by its Transcatheter Mitral and Tricuspid Therapies segment, which is growing over 50% year-over-year. The company's core Transcatheter Aortic Valve Replacement franchise generates over $4.5 billion in annual revenue with 12%-plus growth. Trading at approximately $78, Edwards Lifesciences maintains 78% gross margins and $3.8 billion in cash. At 21.3 times EV/NTM EBITDA, the valuation sits below its historical average of 26 times, with expected EBITDA growth of 10–11% CAGR. Sixty-four hedge funds held positions at the end of the third quarter.

INACTIVE